12 Month Price Forecast For GLT
Distance to GLT Price Forecasts
GLT Price Momentum
🤔 Considering Glatfelter (GLT)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 11:02 PM UTC
GLT Analyst Ratings & Price Targets
GLT has shown a year-to-date change of 14.1% and a 1-year change of -28.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for GLT. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GLT Analyst Consensus
GLT Price Target Range
Latest GLT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GLT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 26, 2021 | BMO Capital | Mark Wilde | Outperform | Upgrade | $17.00 |
| May 10, 2021 | BMO Capital | Mark Wilde | Market Perform | Maintains | $17.00 |
| Apr 20, 2021 | BMO Capital | Mark Wilde | Market Perform | Downgrade | $19.00 |
| Feb 13, 2019 | BMO Capital | Mark Wilde | Outperform | Maintains | $18.00 |
| Oct 10, 2018 | Sidoti & Co. | Buy | Maintains | $25.00 | |
| Aug 23, 2018 | BMO Capital | Mark Wilde | Outperform | Maintains | $26.00 |
| Jan 21, 2015 | Deutsche Bank | Hold | Downgrade | $27.00 | |
| Oct 30, 2013 | Deutsche Bank | Hold | Maintains | $28.00 | |
| Jul 30, 2013 | DA Davidson | Buy | Maintains | $34.00 | |
| May 1, 2013 | DA Davidson | Buy | Maintains | $30.00 | |
| Apr 11, 2013 | DA Davidson | Buy | Maintains | $28.00 | |
| Mar 27, 2013 | Deutsche Bank | Buy | Maintains | $26.00 | |
| Mar 14, 2013 | DA Davidson | Buy | Maintains | $25.00 | |
| Feb 8, 2013 | DA Davidson | Buy | Maintains | $23.00 |
Stocks Similar to PH Glatfelter Co
The following stocks are similar to Glatfelter based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
PH Glatfelter Co (GLT) Financial Data
PH Glatfelter Co has a market capitalization of $73.67M with a P/E ratio of -0.9x. The company generates $1.31B in trailing twelve-month revenue with a -5.1% profit margin.
Revenue growth is +0.7% quarter-over-quarter, while maintaining an operating margin of +0.9% and return on equity of -30.7%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
PH Glatfelter Co (GLT) Company Overview
About PH Glatfelter Co
Acquired company specializing in nonwoven fabrics.
The company generated revenue primarily through the production and sale of specialty nonwoven fabrics, catering to various industries including hygiene, medical, and industrial applications. Its business model focused on delivering innovative and sustainable solutions to its clients.
As of November 4, 2024, Glatfelter Corporation was acquired by the Health, Hygiene and Specialties Global Nonwovens and Films Business of Berry Global Group, Inc., indicating a strategic move to enhance product offerings in the nonwoven sector.
Company Information
Sector
Basic Materials
Industry
Paper & Paper Products
Employees
2,867
CEO
Mr. Thomas M. Fahnemann
Country
United States
IPO Year
1984
Website
www.glatfelter.comPH Glatfelter Co (GLT) Latest News & Analysis
Glatfelter Corporation has merged its business with Berry Global's Health, Hygiene and Specialties division, forming Magnera, the largest nonwovens company. Magnera will trade under ticker "MAGN" starting Nov. 5, 2024.
The merger creates the largest nonwovens company, enhancing market share and product offerings, which could lead to increased revenues and investor confidence in Magnera's growth potential.
Glatfelter Reports Third Quarter 2024 Results
3 months agoThe transaction closing and transition to Magnera are set for November 4th.
The scheduled transaction closing and transition to Magnera on November 4th could impact stock prices, operational efficiency, and market confidence in the involved companies.
GLT reported a widened loss in Q3 due to increased input costs and market volatility, though strategic shifts and growth in the Spunlace segment indicate resilience.
GLT's widening loss due to rising costs and market volatility raises concerns about profitability, but growth in the Spunlace segment indicates potential for future recovery and resilience.
Glatfelter has announced a reverse stock split ratio and its anticipated effective date. Further details on the ratio and timing were not specified in the excerpt.
A reverse stock split can impact share price, liquidity, and investor perception, potentially signaling financial distress or an effort to meet listing requirements.
Glatfelter shareholders approved the merger with Berry Global's Health, Hygiene, and Specialties Nonwovens and Films business, as detailed in the proxy statement.
The merger approval signals potential growth and synergies between Glatfelter and Berry, likely impacting stock performance and market positioning in the nonwovens sector.
Berry Global Group will spin off its Health, Hygiene and Specialties business, merging it with Glatfelter, which will be renamed Magnera Corporation. Completion is expected on November 4, 2024.
The spin-off and merger can reshape Berry and Glatfelter's market positions, impacting stock valuations and investor strategies related to both companies.
Frequently Asked Questions About GLT Stock
What is PH Glatfelter Co's (GLT) stock forecast for 2025?
Analyst forecasts for PH Glatfelter Co (GLT) are not currently available. The stock is trading at $20.57.
Is GLT stock a good investment in 2025?
According to current analyst ratings, GLT has 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $20.57. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for GLT stock?
Price predictions from Wall Street analysts for GLT are not currently available. The stock is trading at $20.57.
What is PH Glatfelter Co's business model?
The company generated revenue primarily through the production and sale of specialty nonwoven fabrics, catering to various industries including hygiene, medical, and industrial applications. Its business model focused on delivering innovative and sustainable solutions to its clients.
What is the highest forecasted price for GLT PH Glatfelter Co?
Price targets from Wall Street analysts for GLT are not currently available. The stock is trading at $20.57.
What is the lowest forecasted price for GLT PH Glatfelter Co?
Price targets from Wall Street analysts for GLT are not currently available. The stock is trading at $20.57.
What is the overall GLT consensus from analysts for PH Glatfelter Co?
The overall analyst consensus for GLT is neutral. Out of 2 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 0 as Sell.
How accurate are GLT stock price projections?
Stock price projections, including those for PH Glatfelter Co, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
